Xiao Wu

机构：Nanchang University, First Affiliated Hospital of Jiangxi Medical College, First Affiliated Hospital of Nanchang University

发表论文 19 篇 · 总被引 383 次 · h-index 9

代表论文

• Nintedanib Ameliorates Bleomycin-Induced Pulmonary Fibrosis, Inflammation, Apoptosis, and Oxidative Stress by Modulating PI3K/Akt/mTOR Pathway in Mice (2023 · Inflammation · 被引 131)
• Ivermectin has New Application in Inhibiting Colorectal Cancer Cell Growth (2021 · Frontiers in Pharmacology · 被引 55)
• Tachykinin NK1 receptor antagonist L-733,060 and substance P deletion exert neuroprotection through inhibiting oxidative stress and cell death after traumatic brain injury in mice (2018 · The International Journal of Biochemistry & Cell Biology · 被引 53)
• Nintedanib alleviates pulmonary fibrosis in vitro and in vivo by inhibiting the FAK/ERK/S100A4 signalling pathway (2022 · International Immunopharmacology · 被引 33)
• Altered M1/M2 polarization of alveolar macrophages is involved in the pathological responses of acute silicosis in rats in vivo (2022 · Toxicology and Industrial Health · 被引 28)
• Identification of immune biomarkers associated with basement membranes in idiopathic pulmonary fibrosis and their pan-cancer analysis (2023 · Frontiers in Genetics · 被引 14)